FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37702351> ?p ?o ?g. }

• Q37702351 description "article científic" @default.
• Q37702351 description "article scientifique" @default.
• Q37702351 description "articolo scientifico" @default.
• Q37702351 description "artigo científico" @default.
• Q37702351 description "artículu científicu espublizáu en 2016" @default.
• Q37702351 description "bilimsel makale" @default.
• Q37702351 description "scientific article published on 19 October 2016" @default.
• Q37702351 description "vedecký článok" @default.
• Q37702351 description "vetenskaplig artikel" @default.
• Q37702351 description "videnskabelig artikel" @default.
• Q37702351 description "vědecký článek" @default.
• Q37702351 description "wetenschappelijk artikel" @default.
• Q37702351 description "wissenschaftlicher Artikel" @default.
• Q37702351 description "наукова стаття, опублікована в жовтні 2016" @default.
• Q37702351 description "научни чланак" @default.
• Q37702351 description "مقالة علمية نشرت في 19 أكتوبر 2016" @default.
• Q37702351 name "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 name "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 name "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma." @default.
• Q37702351 type Item @default.
• Q37702351 label "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 label "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 label "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma." @default.
• Q37702351 prefLabel "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 prefLabel "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 prefLabel "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma." @default.
• Q37702351 P1433 Q37702351-EC6EA491-E5C8-4659-B279-EF816FF3AAC7 @default.
• Q37702351 P1476 Q37702351-02AD2BE5-CF9F-4006-8CC5-10452533E958 @default.
• Q37702351 P2093 Q37702351-25B9A34D-6E89-402C-ADE7-0FD9A95F9820 @default.
• Q37702351 P2093 Q37702351-74EB9465-C37D-40E9-B375-87ECC6486E2F @default.
• Q37702351 P2093 Q37702351-9636F458-B0E3-48AE-8F3F-00B885C9A2DC @default.
• Q37702351 P2093 Q37702351-A886635F-89DE-4226-AFDB-DE240C87286A @default.
• Q37702351 P2093 Q37702351-B477EB32-5B81-4FED-B566-1FA797573439 @default.
• Q37702351 P2093 Q37702351-C7B2E2C1-821D-4E98-8C2F-777BF20EE269 @default.
• Q37702351 P2860 Q37702351-06B77135-A9EB-408E-92F9-519E709C4BFA @default.
• Q37702351 P2860 Q37702351-0BF9C183-DE9C-45B3-BCA9-F59AB7BC7CAA @default.
• Q37702351 P2860 Q37702351-0EF8E21C-1E58-42F3-A202-BB7A9A656771 @default.
• Q37702351 P2860 Q37702351-1348811A-8B61-4318-893C-B36F3E015F7F @default.
• Q37702351 P2860 Q37702351-15B48366-38D9-46F7-8793-771D73181E23 @default.
• Q37702351 P2860 Q37702351-24995FA3-CC28-45A7-A9B0-D468E29D083C @default.
• Q37702351 P2860 Q37702351-25F2C7AB-A5A5-42C4-A5EC-2C61A92B10AD @default.
• Q37702351 P2860 Q37702351-2EC3D984-C98D-4FD3-AB28-945C6F82D118 @default.
• Q37702351 P2860 Q37702351-2F0BB091-9D2F-4B28-8F31-915682C7F0B0 @default.
• Q37702351 P2860 Q37702351-2F6379C7-C51F-4BDE-AACF-161F6E19AFBC @default.
• Q37702351 P2860 Q37702351-3A86F374-765B-49C8-B0DB-EA144343BCC7 @default.
• Q37702351 P2860 Q37702351-3C6F454F-269C-4F8F-B00E-33EC78BFD5A3 @default.
• Q37702351 P2860 Q37702351-3EC6B60D-439D-44DC-9652-CEC9A2C6A9E9 @default.
• Q37702351 P2860 Q37702351-42C30993-9C51-410F-BC56-E3C1A456A01A @default.
• Q37702351 P2860 Q37702351-4321A723-E93D-4D36-8312-0701AAC918F3 @default.
• Q37702351 P2860 Q37702351-4865D8F0-5AE1-4365-A191-19BA4BA7B7A4 @default.
• Q37702351 P2860 Q37702351-50DB38CB-36FB-4471-973E-D31AC25BB391 @default.
• Q37702351 P2860 Q37702351-54C9101A-FD79-432F-8BEA-D50D51A50513 @default.
• Q37702351 P2860 Q37702351-57E30D5B-4824-4525-9831-13615C1B6D72 @default.
• Q37702351 P2860 Q37702351-5EE49B32-A124-498C-8B9E-555C7F32A7AB @default.
• Q37702351 P2860 Q37702351-63548F5C-D4AB-4A7E-B2B9-0EF8BDE0C1D7 @default.
• Q37702351 P2860 Q37702351-7109E4EF-E218-4A17-B50D-5200C65F5903 @default.
• Q37702351 P2860 Q37702351-762350EF-A514-4740-B9FC-7FF6754292C3 @default.
• Q37702351 P2860 Q37702351-769B8363-19F0-477B-A370-15389D9A2229 @default.
• Q37702351 P2860 Q37702351-79EF6D5B-452D-4DFC-926B-9D82DADEEF9E @default.
• Q37702351 P2860 Q37702351-7BB8043A-D726-414C-94DE-7AC930112D47 @default.
• Q37702351 P2860 Q37702351-7C6292C2-7DE1-4081-83EA-5E3E2749E6A8 @default.
• Q37702351 P2860 Q37702351-8601500C-9BF2-47C1-8186-5DD11B8E706B @default.
• Q37702351 P2860 Q37702351-86C85BBA-FFB8-4D5D-8F88-F54645B3BCBA @default.
• Q37702351 P2860 Q37702351-8B1B98DF-33EB-4B7B-822B-C7661216899E @default.
• Q37702351 P2860 Q37702351-A0832576-C4DA-4331-BF22-C8F4908A7C9F @default.
• Q37702351 P2860 Q37702351-A9849483-B89A-4260-B952-6E69774EBD72 @default.
• Q37702351 P2860 Q37702351-B6E52EC3-5DD5-4229-9085-A1C1DD424829 @default.
• Q37702351 P2860 Q37702351-B72F80A4-ECE8-414A-B84A-7BB0F93C95D0 @default.
• Q37702351 P2860 Q37702351-B8606CCC-2D36-46D0-AB89-A19BF70FB8C4 @default.
• Q37702351 P2860 Q37702351-BEF10B4A-200F-4E7B-AAD4-C4AD9C6E34E2 @default.
• Q37702351 P2860 Q37702351-D4D65A12-8826-4D58-B128-79894C810C7C @default.
• Q37702351 P2860 Q37702351-D7DDFF2B-1B70-4715-B110-53E3A7246868 @default.
• Q37702351 P2860 Q37702351-DE0CF141-89E7-45D6-8268-12296F78A7D3 @default.
• Q37702351 P2860 Q37702351-DED51318-9C1F-424C-B04E-281371A8AA50 @default.
• Q37702351 P2860 Q37702351-E9BC4916-095F-44BB-8E93-6D7DDDCA14D1 @default.
• Q37702351 P2860 Q37702351-EF2AA9F2-2167-49CB-B722-C9FDC89155A1 @default.
• Q37702351 P2860 Q37702351-F298574B-C343-4945-8E1B-926960B158FC @default.
• Q37702351 P2860 Q37702351-F76DCE85-C83D-48E1-AB50-8AA78E012A10 @default.
• Q37702351 P2860 Q37702351-F79B3183-4183-4303-8FCD-884E090CDEB3 @default.
• Q37702351 P2860 Q37702351-FD031F36-4B4C-4450-8615-411A86A15E77 @default.
• Q37702351 P304 Q37702351-031634FF-2B41-4C0A-A82D-077426A328D5 @default.
• Q37702351 P31 Q37702351-D2C070DA-F801-49E9-AED2-E67C170A304F @default.
• Q37702351 P356 Q37702351-83A74951-5056-472B-86C2-B4FEDFC0ECDD @default.
• Q37702351 P407 Q37702351-62F67C16-09C2-416D-8860-75BB855B74DE @default.
• Q37702351 P433 Q37702351-4844E37A-8E5F-4835-B49A-41E9E4FBA351 @default.
• Q37702351 P4510 Q37702351-DC4FB521-72E3-471F-BDCD-E457D406BF58 @default.
• Q37702351 P478 Q37702351-7564178C-7D1B-4F37-B5FA-1FEAB6D2F48A @default.
• Q37702351 P50 Q37702351-5741B589-8E9E-4BE2-8F76-34255CC2EC1C @default.
• Q37702351 P50 Q37702351-823DD918-8877-4647-B41D-2783456E91E5 @default.
• Q37702351 P50 Q37702351-AF9D376B-A723-44AF-8D72-5BF1C69EF13B @default.
• Q37702351 P577 Q37702351-23E68F7E-DE94-442C-AE77-8BD686B3B7C5 @default.
• Q37702351 P698 Q37702351-60DE2B0C-5020-4F17-9F00-C408B5B91C0B @default.
• Q37702351 P921 Q37702351-66A308FD-0D91-41D3-9001-43C2A4C80E71 @default.
• Q37702351 P932 Q37702351-68E812D9-EE0B-414B-9AAE-68BEC61B06EC @default.
• Q37702351 P356 ONCOTARGET.12748 @default.
• Q37702351 P698 27768593 @default.
• Q37702351 P1433 Q1573155 @default.
• Q37702351 P1476 "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma" @default.
• Q37702351 P2093 "Boris Redko" @default.
• Q37702351 P2093 "Dror Tobi" @default.

• next